TiumBio Co., Ltd. (KOSDAQ:321550)
South Korea · Delayed Price · Currency is KRW 4,440.00
-35.00 (-0.78%)
At close: Sep 23, 2026
TiumBio Market Cap
TiumBio has a market cap or net worth of 133.37 billion as of September 25, 2026. Its market cap has decreased by -14.42% in one year.
Market Cap
133.37B
Enterprise Value
140.46B
Revenue
15.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,440.00
ChartMarket Cap Chart
Since November 22, 2019, TiumBio's market cap has decreased from 311.90B to 133.37B, a decrease of -57.24%. That is a compound annual growth rate of -11.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 133.37B | -21.82% |
| Dec 30, 2025 | 170.58B | 51.78% |
| Dec 30, 2024 | 112.39B | -53.28% |
| Dec 28, 2023 | 240.56B | -20.51% |
| Dec 29, 2022 | 302.63B | -34.44% |
| Dec 30, 2021 | 461.60B | -7.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NIBEC | 173.70B |
| Bio Solution | 164.89B |
| Kanaph Therapeutics | 159.34B |
| Ensol Biosciences | 145.63B |
| ISU Abxis | 143.73B |
| Y-Biologics | 128.16B |
| ViGenCell | 117.26B |
| Prestige Biologics | 106.05B |